Form 4 for RLYB Rallybio Corp

Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001209191-22-031969 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-05-25	2022-05-23	RLYB	PARMAR KUSH	Dir, 10%	S - Sale	$13.00	-100.0K	1.30M	-7%	-$1.30M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-23	S	D	66,447	$13.00	2,578,640	I By 5AM Ventures V, L.P.	—	—	(F1) These securities are held directly by 5AM Ventures V, L.P. ("Ventures V"). 5AM Partners V, LLC ("Partners V") is the sole general partner of Ventures V. Dr. Parmar is a managing member of Partners V and may be deemed to share voting and investment power over the securities held by Ventures V. Dr. Parmar disclaims beneficial ownership of the securities held by Ventures V except to the extent of his pecuniary interest therein.
2	Common	Common Stock	2022-05-23	S	D	33,553	$13.00	1,302,084	I By 5AM Opportunities I, L.P.	—	—	(F2) These securities are held directly by 5AM Opportunities I, L.P. ("Opportunities I, L.P."). 5AM Opportunities I (GP), LLC ("Opportunities I (GP)") is the general partner of Opportunities I, L.P. Dr. Parmar is a managing member of Opportunities I (GP), and may be deemed to share voting and dispositive power over the securities held by Opportunities I, L.P. Dr. Parmar disclaims beneficial ownership of the securities held by Opportunities I, L.P. except to the extent of his pecuniary interest therein.